Entertainment venue operator Lucky Strike (NYSE:LUCK) will be reporting results this Wednesday afternoon. Here’s what to expect.
New clinical data supports ERLEADA for metastatic castration sensitive prostate cancer, reinforcing its role in current treatment practice. DARZALEX FASPRO received expanded FDA approval for newly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results